VIEMED HEALTHCARE, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
VIEMED HEALTHCARE, INC. (VMD) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2020-03-31 was 7.44 CAD/shares.
- VIEMED HEALTHCARE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2019 was 5.77 CAD/shares, a 154.19% increase from fiscal 2018.
- VIEMED HEALTHCARE, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2018 was 2.27 CAD/shares.
CAD/shares
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2020-06-30 | 7.44 CAD/shares 10-Q · filed 2020-08-04 | |||
| 2020-03-31 | 7.44 CAD/shares 10-Q · filed 2020-05-05 | |||
| 2019-12-31 | 5.77 CAD/shares 10-K · filed 2020-03-04 | |||
| 2019-09-30 | 5.66 CAD/shares 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | 5.66 CAD/shares 10-Q · filed 2019-08-09 | |||
| 2018-12-31 | 2.27 CAD/shares 10-K · filed 2020-03-04 |
USD/shares
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-04 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-04 | |||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-06 | |||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-06 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-03-04 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-01 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-08 | |||
| 2022-12-31 | $5.29 10-K · filed 2025-03-10 | |||
| 2022-09-30 | $5.29 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | $5.22 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | $5.21 10-Q · filed 2022-05-03 | |||
| 2021-12-31 | $8.44 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $8.60 10-Q · filed 2021-11-02 | |||
| 2021-06-30 | $8.60 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $8.57 10-Q · filed 2021-05-03 | |||
| 2020-12-31 | $6.18 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $6.10 10-Q · filed 2020-11-04 | |||
| 2019-12-31 | $4.34 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |